Lv610
1950 积分 2026-01-12 加入
Sarcopenic obesity may predict worse liver regeneration after right graft living donor liver transplantation
1天前
已完结
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
4个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
4个月前
已完结
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
6个月前
已完结
Perioperative approaches for patients with biliary tract cancer
6个月前
已完结
Inactivating LATS2 Variation Drives Tumor Progression and Resistance to Anti-PD-1 Therapy in Intrahepatic Cholangiocarcinoma
6个月前
已关闭
Isocitrate Dehydrogenase Mutations in Cancer: Mechanisms of Transformation and Metabolic Liability
8个月前
已完结
Biology of IDH mutant cholangiocarcinoma
8个月前
已完结
Cholangiocarcinoma — novel biological insights and therapeutic strategies
8个月前
已完结
Cancer cell metabolism and antitumour immunity
9个月前
已完结
皖公网安备34019202002308
